{"id":501,"date":"2025-04-01T09:30:02","date_gmt":"2025-04-01T09:30:02","guid":{"rendered":"https:\/\/iefm.health\/public\/?page_id=501"},"modified":"2026-04-13T14:02:14","modified_gmt":"2026-04-13T14:02:14","slug":"r2h-2025","status":"publish","type":"page","link":"https:\/\/iefm.health\/public\/events\/r2h-2025\/","title":{"rendered":"2025 Post-infectious Diseases"},"content":{"rendered":"\n
\n
\n
\n
<\/div>\n\n\n\n

Symposium 2025<\/h1>\n\n\n\n

“New ways to unburden”<\/h2>\n\n\n\n

<\/p>\n\n\n\n

Special Focus: Post-infectious Diseases <\/h3>\n\n\n\n

17th and 18th October 2025 \u00b7 Conference Hotel Schloss Marbach, Germany (Bodensee)


<\/p>\n<\/div>\n\n\n\n

\n
\n
\"\"<\/figure>\n<\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n

<\/p>\n\n\n\n

We were delighted to host around 80 international guests for the #Unburden2025 symposium, set in the magnificent surroundings of Hotel Schloss Marbach.<\/p>\n\n\n\n

True to our guiding theme “The science of less”, <\/em>this annual gathering brought together leading clinicians, researchers, and partners united by one conviction: that modern medicine is not only about adding more, but about knowing what to take away<\/em>. Over two inspiring days, our attendees exchanged knowledge and explored new science, all focused on shaping a future where the weight of modern disease grows lighter and the possibilities for human health grow greater.<\/p>\n\n\n\n

<\/p>\n\n\n\n

\n
\n
\n
\n
\n\n\n\n
<\/div>\n\n\n\n

Unburden Compendium 2025<\/h2>\n\n\n\n
\"\"<\/a><\/figure>\n\n\n\n

The scientific volume from our “Unburden 2025” symposium is now available. This compendium collects expert contributions under the theme \u201cUnburden \u2013 Holistic Relief in a Modern Context.\u201d<\/em> It highlights innovative therapeutic approaches for chronic conditions, environmental medicine, and post-infectious syndromes, focusing on the systematic relief of the organism.<\/p>\n\n\n\n

Published in cooperation with Lehmanns Media, the compendium is available as a hardcover or e-book directly from the publisher.<\/p>\n\n\n\n

\n
Order now<\/a><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Gallery<\/h2>\n<\/div>\n<\/div>\n\n\n\n

We invite you to explore the best moments and impressions from this inspiring event in the photo gallery below.<\/p>\n\n\n\n

\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/figure>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\n\n\n
<\/div>\n\n\n\n

Speakers<\/h2>\n\n\n\n

Below you can find a selection of our speakers.<\/p>\n\n\n\n

\n
\n
\"\"
Prof. Dr. Stefan R. Bornstein<\/strong> – Director of Medical Clinic and Polyclinic III, University Hospital Carl Gustav Carus Dresden<\/figcaption><\/figure>\n\n\n\n
\"\"
Stefan Heckel<\/strong>–Reusser<\/strong> – Expert in the field of hyperthermia; Owner and CEO heckel medizintechnik GmbH<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"\"
Prof. Dr. Alessio Vigani<\/strong> – Professor in Small Animal Emergency, Critical Care, And Extracorporeal Therapy, University of Zurich<\/figcaption><\/figure>\n\n\n\n
\"\"
Dr. med. Ralf Oettmeier<\/strong> – Head Physician at the Alpstein Clinic Gais<\/figcaption><\/figure>\n\n\n\n
\"\"
Sylvia Pietzsch<\/strong> – Expert in the field of Microclots, Ayus Laboratories<\/figcaption><\/figure>\n<\/div>\n\n\n\n
\n
\"\"
Doz. Dr. Katharina Kurz<\/strong> – Specialist in internal medicine, additional qualification in infectious diseases and tropical medicine, PhD, Lanserhof Lans<\/figcaption><\/figure>\n\n\n\n
\"\"
Prof. Dr. Ludwig Aigner<\/strong> – Head of Institute, Paracelsus Medical University<\/figcaption><\/figure>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n
\n\n\n\n


Agenda<\/h2>\n\n\n\n

Simultaneous translation of all German keynotes into English and vice versa was provided.
The presentations lasted approximately 35 minutes each and there was time for Q&A immediately afterwards.
<\/p>\n\n\n\n

\n
\n
\n

Friday – 17th October 2025<\/strong><\/h3>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n

10:00<\/strong> Welcome Address <\/h4>\n<\/div>\n\n\n\n
\n
Introductory remarks by the hosts<\/summary>\n

Ayus Medical Devices AG and the Swiss Institue for Environmental and Functional Medicine (IEFM) warmly welcome you to this year’s convention.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

10:30<\/strong> Prof. Dr. Stefan R. Bornstein<\/h4>\n<\/div>\n\n\n\n
\n
New developments and new indications for apheresis therapy<\/summary>\n

In apheresis therapy, we see many new developments that go far beyond the established treatments in lipid apheresis. There are completely new approaches in the field of dementia. We will present initial data on pulmonary fibrosis and liver steatosis. There are also important new findings in the areas of chronic fatigue, post-COVID and autoimmune diseases. The therapeutic potential of apheresis is far from exhausted, and we are only at the beginning of making better use of this therapy for our patients.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

11:15<\/strong> Prof. Dr. Alessio Vigani<\/h4>\n<\/div>\n\n\n\n
\n
Therapeutic application of plasmapheresis and double filtration plasmapheresis to unconventional patients: They may have paws and a tail but their immune system works the same.<\/summary>\n

Plasmapheresis is a crucial therapy for acute post-infectious immune-mediated diseases, offering rapid immunomodulation and improved clinical outcomes. In small animal medicine, both standard plasmapheresis and double filtration plasmapheresis are emerging as novel therapeutic options for treating these conditions, where the immune system, triggered by a prior infection, mistakenly attacks the body\u2019s own tissues.<\/p>\n\n\n\n

One key application is in polyradiculoneuritis in dogs, a Guillain-Barr\u00e9-like syndrome. Plasmapheresis helps by removing harmful antibodies, reducing disease severity while expediting neurologic recovery. Similarly, in myasthenia gravis, which may be exacerbated by infections, TPE is used during acute crises to remove autoantibodies against acetylcholine receptors.<\/p>\n\n\n\n

Post-infectious glomerulonephritis (POGN) and immune-mediated hemolytic anemia (IMHA) are other conditions where plasmapheresis has been proven effective and superior to medical management alone. In acute POGN, removing immune complexes and autoantibodies prevents damage to the glomerular membrane, reduces proteinuria, and restores renal function. In IMHA, which can follow infections, removing autoantibodies against red blood cells via TPE effectively controls hemolysis.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

12:00<\/strong> Lunch<\/h4>\n<\/div>\n\n\n\n
\n
Joint lunch<\/summary>\n

Lunch will be served in the restaurant of the main building of the hotel.<\/p>\n\n\n\n

<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

13:30<\/strong> Priv. Doz. Dr. Katharina Kurz<\/h4>\n<\/div>\n\n\n\n
\n
The gut, inflammation and neurotransmitters in post-infectious conditions<\/summary>\n

Patients with persistent symptoms after infections often appear to have a combination of different disease mechanisms:
Many of those affected show signs of intestinal dysbiosis, as well as increased inflammation with oxidative and nitrosative stress and overactive coagulation. Data from our ongoing research project also confirm a neurotransmitter imbalance in patients with post-infectious conditions.<\/p>\n\n\n\n

<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

14:15<\/strong> Vincent Peynet<\/h4>\n<\/div>\n\n\n\n
\n
\n
An Innovative Tool in Environmental Medicine to Assess the Individual Exposome<\/summary>\n

Modern life entails daily exposure to hundreds of chemicals through food and drink consumption, air inhalation, and dermal contact. Many of these substances have delayed toxic effects and are suspected of contributing to serious health conditions, including cancer, fertility disorders, neurological dysfunction, and hormonal imbalances.<\/p>\n\n\n\n

Reducing health risks relies heavily on minimizing individual exposure. To effectively prevent the consequences of chronic exposure, it is essential to measure the exposome accurately and reliably. This is typically done through the analysis of biological samples such as blood, urine, or hair. However, such sampling methods can be invasive and pose logistical challenges, especially when it comes to sample transport and storage.<\/p>\n\n\n\n

Recent developments have shown that silicone materials are highly effective in adsorbing a wide spectrum of chemical compounds. This innovative approach provides a valuable alternative for assessing an individual\u2019s exposome and specific chemical exposures in real-life conditions.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

15:00<\/strong> Break<\/h4>\n<\/div>\n\n\n\n
\n
\n
Coffee break<\/summary>\n

The coffee break will take place directly in front of the hall in the foyer.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

15:45<\/strong> Stefan Heckel-Reusser<\/h4>\n<\/div>\n\n\n\n
\n
\n
Fever-range Whole-Body Hyperthermia and its Role in the Treatment of Post-infectious Diseases<\/summary>\n

In infectious diseases, natural fever stimulates and regulates a most effective immune response. However, many people have lost the ability to respond to infections with fever. Heating the organism to fever temperatures between 38,5\u00b0C \u2013 40\u00b0C by fever-range whole-body hyperthermia can partially mimick these immunological fever effects and lead to a \u201cre-set\u201d of the immune system in order to overcome chronic immune dysfunctions in the response to infections.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

16:30<\/strong> Outlook and Recap<\/h4>\n<\/div>\n\n\n\n
\n
Important news and recap of the day<\/summary>\n

Presented by the team of Ayus Medical Devices.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

18:30<\/strong> Dinner<\/h4>\n<\/div>\n\n\n\n
\n
Joint dinner<\/summary>\n

All guests are invited to dinner with a wonderful view of Lake Constance. There will be plenty of time to exchange ideas and discuss the topics of the day in more depth.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
<\/div>\n\n\n\n

Saturday – 18th October 2025<\/strong><\/h3>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n
\n
\n

9:00<\/strong> Dr. med. Ralf Oettmeier<\/h4>\n<\/div>\n\n\n\n
\n
\n
Successful treatment of chronic infections and their consequences<\/summary>\n

Chronic fatigue, fibromyalgia pain, cognitive deficits, joint inflammation and organ weakness are typical consequences of bacterial, viral, parasitic and, increasingly, mold infections. Holistic diagnostics of environmental factors, toxin exposure and the immune situation should be followed by individualized targeted biological therapy. Inuspheresis\u00ae is at the center of this, which, in addition to toxins, can also remove pro-inflammatory cytokines, antigen-antibody complexes, microclots and pathogen fragments.<\/p>\n<\/details>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

9:45<\/strong> Prof. Dr. Ludwig Aigner<\/h4>\n<\/div>\n\n\n\n
\n
Does Aging Make Us Sick \u2013 or Does Illness Make Us Age? The Role of Blood.<\/summary>\n

Major widespread diseases such as stroke, heart attack, diabetes, dementia and cancer are age-related. Due to demographic developments in our society and improvements in medical care over recent decades, the incidence of these diseases is increasing dramatically. Ageing factors in the blood have been proven to contribute to these diseases. Conversely, diseases often have systemic effects on our entire body and cause it to age more quickly. Here, too, it is obvious to postulate that ageing factors in the blood are partly responsible. This lecture will attempt to provide a brief overview of the topic and explain it using a few examples.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

10:30<\/strong> Break<\/h4>\n<\/div>\n\n\n\n
\n
Coffee Break<\/summary>\n

The coffee break will take place directly in front of the hall in the foyer.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

11:00<\/strong> Sylvia Pietzsch<\/h4>\n<\/div>\n\n\n\n
\n
Microclots as a marker of chronic inflammatory disease<\/summary>\n

Are hidden amyloid fibrin microclots and microparticles driving the pathological symptoms patients with chronic inflammatory diseases experience? Emerging research increasingly identifies microclots as critical markers linked to chronic inflammation. At INUS Laboratories AG, we harness cutting-edge imaging flow cytometry techniques to precisely detect and classify these elusive microclots. While microclots themselves are too large to pass through the revolutionary Inuspheresis\u00ae filter, ongoing research investigates whether Inuspheresis\u00ae could reduce microclot presence and ease inflammatory symptoms.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

11:45<\/strong> PD Dr. Rolf Bambauer<\/h4>\n<\/div>\n\n\n\n
\n
Experiences with therapeutic apheresis<\/summary>\n

Teaser will follow shortly.<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

12:30 <\/strong>Wrap-up and goodbye<\/h4>\n<\/div>\n\n\n\n
\n
Summary of key insights from the 1.5-day conference<\/summary>\n

By Ayus Medical Devices and IEFM<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n

13:00 <\/strong>Lunch<\/h4>\n<\/div>\n\n\n\n
\n
Concluding Network Lunch<\/summary>\n

<\/p>\n<\/details>\n<\/div>\n<\/div>\n\n\n\n

\n
\n
<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Moderators<\/h2>\n\n\n\n
\n
\"\"
Dr. med. Philip Mavberg<\/strong> – CSO, Ayus Medical Group<\/figcaption><\/figure>\n\n\n\n
\"\"
Prof. Dr. Stefan R. Bornstein<\/strong> – Director of Medical Clinic and Polyclinic III, University Hospital Carl Gustav Carus Dresden<\/figcaption><\/figure>\n\n\n\n
\"\"
Domenico Fontana<\/strong> – CEO, Ayus Medical Devices<\/figcaption><\/figure>\n<\/figure>\n\n\n\n
<\/div>\n\n\n\n
\n\n\n\n
<\/div>\n\n\n\n

Your Event Host<\/h2>\n\n\n\n
\"\"<\/a><\/figure>\n\n\n\n
<\/div>\n\n\n\n

Supported by<\/h2>\n\n\n\n
\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

Symposium 2025 “New ways to unburden” Special Focus: Post-infectious Diseases 17th and 18th October 2025 \u00b7 Conference Hotel Schloss Marbach, Germany (Bodensee) We were delighted to host around 80 international guests for the #Unburden2025 symposium, set in the magnificent surroundings of Hotel Schloss Marbach. True to our guiding theme “The science of less”, this annual […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":33,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-501","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/comments?post=501"}],"version-history":[{"count":63,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/501\/revisions"}],"predecessor-version":[{"id":779,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/501\/revisions\/779"}],"up":[{"embeddable":true,"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/pages\/33"}],"wp:attachment":[{"href":"https:\/\/iefm.health\/public\/wp-json\/wp\/v2\/media?parent=501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}